MedTrace Logo

Impact of ART Adherence on HIV Persistence and Inflammation

NCT02797093 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2022-03-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the relationship between anti-retroviral therapy (ART) adherence with levels of human immunodeficiency virus (HIV) reservoir and residual viremia in suppressed, HIV-infected individuals on chronic ART.

Conditions

  • Human Immunodeficiency Virus

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Jose R Castillo-Mancilla, MD · University of Colorado, Denver

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-10-12
Completion
2018-10-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02797093 on ClinicalTrials.gov